Home › Funds › Alecta Tjanstepension Omsesidigt › ABT

Alecta Tjanstepension Omsesidigt position in ABT

ABBOTT LABORATORIES · Health Care

Alecta Tjanstepension Omsesidigt reported holding 1,809,700 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$178.8M, representing 0.74% of its reported portfolio and ranking #41 among its reported holdings. Alecta Tjanstepension Omsesidigt has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)1.81M sh
Reported value held$178.82M
Portfolio Weight0.74%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Alecta Tjanstepension Omsesidigt's ABT position evolved

Alecta Tjanstepension Omsesidigt first disclosed a stake in ABT in Q4 2024 at 475,300 shares (US$53.8M). The position peaked in Q2 2025 at 1,388,100 shares, worth US$188.7M. Across 8 filings, Alecta Tjanstepension Omsesidigt increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,809,700 shares valued at US$178.8M — an increase of 200,500 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2025 (shares rose 3% over the following quarter), a 79% increase in Q2 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 475.30K $53.78M New
Q1 2025 775.40K $102.86M Add
Q2 2025 1.39M $188.70M Add
Q3 2025 1.39M $185.92M Hold
Q4 2025 1.39M $173.89M Hold
Q1 2026 1.46M $149.31M Add
Q2 2026 1.61M $145.92M Add
Q3 2026 1.81M $178.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Alecta Tjanstepension Omsesidigt held ABT?

Alecta Tjanstepension Omsesidigt has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Alecta Tjanstepension Omsesidigt's current position in ABT?

As of Q3 2026, Alecta Tjanstepension Omsesidigt holds 1.81M shares of ABT (ABBOTT LABORATORIES), valued at $178.82M, representing 0.74% of its reported portfolio and ranking #41.

Has Alecta Tjanstepension Omsesidigt been buying or selling ABT?

In the latest 13F filing (Q3 2026), Alecta Tjanstepension Omsesidigt increased its position in ABT. The position peaked in Q2 2025 at 1.39M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.